医学
疾病
重症监护医学
心血管健康
免疫系统
内科学
免疫学
标识
DOI:10.1038/s41569-021-00594-5
摘要
Nanotherapies are emerging rapidly as options to treat cardiovascular disease. However, insufficient and heterogeneous delivery remain critical issues. Novel strategies to boost targeted delivery of systemically administered nanoparticles by optimizing the particle physical properties or using immune cells as carriers promise to increase nanotherapeutic effectiveness in cardiovascular and other inflammatory diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI